IRF5 and IRF4 balance each other, and reducing the expression of IRF5 can promote M2-type activation, increase IRF4 expression, inhibit the inflammatory response, and improve outcomes in cerebral ischemia. The gene discussed is IRF5; the disease is Cerebral ischemia.